[{"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-001", "question": "A 52-year-old male presents with severe chronic watery diarrhea and 15 kg weight loss over 6 months. He has a history of hypertension treated with olmesartan and amlodipine. Celiac serologies (tTG-IgA, EMA) are negative. Upper endoscopy reveals scalloping of duodenal folds; biopsy shows total villous atrophy and increased intraepithelial lymphocytes. HLA-DQ2 and HLA-DQ8 genotyping is negative. A gluten-free diet for 8 weeks yields no clinical improvement. What is the most likely diagnosis?", "options": ["Refractory Celiac Disease Type 1", "Autoimmune Enteropathy", "Olmesartan-associated Enteropathy", "Common Variable Immunodeficiency (CVID)", "Tropical Sprue"], "answer": "C", "answer_index": 2, "explanation": "Olmesartan-associated enteropathy mimics celiac disease histologically (villous atrophy) but occurs in patients without the genetic predisposition for celiac disease (HLA-DQ2/DQ8 negative). The key discriminator is the medication history and lack of response to gluten withdrawal. Refractory celiac disease requires a prior confirmed diagnosis of celiac disease (positive genetics/serology).", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V. Verdict: Correct best answer. Key stem clues: chronic watery diarrhea, weight loss, negative tTG-IgA and EMA, negative HLA-DQ2/DQ8, total villous atrophy with increased intraepithelial lymphocytes, no response to gluten-free diet, and use of olmesartan. These findings are classic for olmesartan-associated enteropathy, which mimics celiac disease histologically but lacks serologic and genetic markers and does not improve with gluten withdrawal. Alternative options are appropriately excluded: refractory celiac disease requires prior confirmed celiac disease; autoimmune enteropathy is rare in adults and usually associated with other autoimmunity; CVID would present with recurrent infections and hypogammaglobulinemia; tropical sprue is linked to travel and responds to antibiotics. No internal contradictions or missing critical details. The item discriminates well. Medical accuracy: the description of olmesartan-induced enteropathy aligns with current literature and guideline recognition. No safety concerns. Minimal fix: none required.\",\n\"medical_accuracy_score\":  \t \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. Key stem clues: chronic watery diarrhea, weight loss, negative tTG-IgA and EMA, negative HLA-DQ2/DQ8, total villous atrophy with increased intraepithelial lymphocytes, no response to gluten-free diet, and use of olmesartan. These findings are classic for olmesartan-associated enteropathy, which mimics celiac disease histologically but lacks serologic and genetic markers and does not improve with gluten withdrawal. Alternative options are appropriately excluded: refractory celiac disease requires prior confirmed celiac disease; autoimmune enteropathy is rare in adults and usually associated with other autoimmunity; CVID would present with recurrent infections and hypogammaglobulinemia; tropical sprue is linked to travel and responds to antibiotics. No internal contradictions or missing critical details. The item discriminates well. Medical accuracy: the description of olmesartan-induced enteropathy aligns with current literature and guideline recognition. No safety concerns. Minimal fix: none required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-002", "question": "A 34-year-old female with a history of oral contraceptive use presents with right upper quadrant pain. MRI of the liver reveals a 6 cm solitary lesion in segment V. The lesion is hyperintense on T2-weighted images, shows strong arterial enhancement, and retains contrast on the hepatobiliary phase of Eovist (gadoxetate) MRI. Biopsy shows hepatocytes with glutamine synthetase diffuse strong positivity. What is the most appropriate management?", "options": ["Discontinue oral contraceptives and surveillance imaging in 6 months", "Surgical resection", "Radiofrequency ablation", "Liver transplantation evaluation", "Reassurance and discharge"], "answer": "B", "answer_index": 1, "explanation": "The imaging and staining pattern (diffuse glutamine synthetase positivity) are diagnostic of a beta-catenin activated hepatocellular adenoma. Unlike HNF1A-inactivated or inflammatory adenomas, beta-catenin activated adenomas have a very high risk of malignant transformation to hepatocellular carcinoma (HCC) and do not regress significantly with OCP cessation. Resection is mandated regardless of size or symptoms.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V. Verdict: Correct best answer. Diffuse glutamine synthetase positivity on biopsy definitively identifies a beta-catenin activated hepatocellular adenoma (HCA), which carries 30-40% hepatocellular carcinoma risk. Key discriminating features: 6 cm size, beta-catenin activation, and symptomatic presentation. Current guidelines mandate surgical resection for beta-catenin activated HCAs regardless of size due to malignant potential; lesions >5 cm also have elevated hemorrhage risk. Option B is uniquely defensible: resection removes oncologic threat and symptomatic mass. Alternatives are inferior: A/E ignore malignant potential; C is ineffective for 6 cm lesions and precludes definitive pathology; D is excessive for solitary, anatomically resectable adenoma in a non-cirrhotic liver. No logical contradictions exist—the biopsy gold standard supersedes atypical imaging features. Medical accuracy is excellent: the association between diffuse glutamine synthetase and beta-catenin activation is pathognomonic, and resection aligns with AASLD/EASL consensus. Minimal fix: None required.\",\n\"medical_accuracy_score\":   \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. Diffuse glutamine synthetase positivity on biopsy definitively identifies a beta-catenin activated hepatocellular adenoma (HCA), which carries 30-40% hepatocellular carcinoma risk. Key discriminating features: 6 cm size, beta-catenin activation, and symptomatic presentation. Current guidelines mandate surgical resection for beta-catenin activated HCAs regardless of size due to malignant potential; lesions >5 cm also have elevated hemorrhage risk. Option B is uniquely defensible: resection removes oncologic threat and symptomatic mass. Alternatives are inferior: A/E ignore malignant potential; C is ineffective for 6 cm lesions and precludes definitive pathology; D is excessive for solitary, anatomically resectable adenoma in a non-cirrhotic liver. No logical contradictions exist—the biopsy gold standard supersedes atypical imaging features. Medical accuracy is excellent: the association between diffuse glutamine synthetase and beta-catenin activation is pathognomonic, and resection aligns with AASLD/EASL consensus. Minimal fix: None required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-003", "question": "A 24-year-old female presents with menorrhagia and prolonged bleeding after a tooth extraction. Coagulation profile shows a prolonged aPTT (55s) and normal PT. Factor VIII activity is 6% (low). von Willebrand Factor (vWF) Antigen is 95% (normal), and vWF Ristocetin Cofactor Activity is 92% (normal). A mixing study corrects the aPTT. Her father has a similar bleeding history, but her brothers are unaffected. What is the most likely diagnosis?", "options": ["Hemophilia A (Carrier state)", "Type 2N von Willebrand Disease", "Type 2A von Willebrand Disease", "Acquired Hemophilia A", "Factor XI Deficiency"], "answer": "B", "answer_index": 1, "explanation": "Type 2N (Normandy) vWD is caused by a defect in the vWF binding domain for Factor VIII, leading to a secondary deficiency of Factor VIII (due to short half-life) despite normal vWF levels and function. It mimics Hemophilia A but exhibits autosomal recessive inheritance (affecting females significantly), whereas Hemophilia A is X-linked. The normal vWF antigen and activity rule out Type 1 and 2A/2B/2M.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Hematology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. Key stem clues: isolated prolonged aPTT (55s), markedly reduced Factor VIII (6%), normal vWF antigen and ristocetin cofactor activity, mixing study correction, and autosomal-appearing inheritance (affected father, unaffected brothers) in a female with menorrhagia. These findings uniquely indicate Type 2N vWD, where defective vWF-FVIII binding causes secondary FVIII deficiency despite normal vWF levels. The keyed answer (B) is well-supported: 2N vWD mimics hemophilia A but follows autosomal recessive inheritance, explaining significant bleeding in females. Alternative options are appropriately discriminated: Hemophilia A carrier state would have milder FVIII reduction (typically >25-30%) and X-linked inheritance cannot explain the pattern; Type 2A vWD would show decreased vWF activity; Acquired Hemophilia A would have a non-correcting mixing study; Factor XI deficiency would affect FXI, not FVIII. No logical flaws or medical inaccuracies. Minimal fix: None required.\",\"medical_accuracy_score\":   \"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. Key stem clues: isolated prolonged aPTT (55s), markedly reduced Factor VIII (6%), normal vWF antigen and ristocetin cofactor activity, mixing study correction, and autosomal-appearing inheritance (affected father, unaffected brothers) in a female with menorrhagia. These findings uniquely indicate Type 2N vWD, where defective vWF-FVIII binding causes secondary FVIII deficiency despite normal vWF levels. The keyed answer (B) is well-supported: 2N vWD mimics hemophilia A but follows autosomal recessive inheritance, explaining significant bleeding in females. Alternative options are appropriately discriminated: Hemophilia A carrier state would have milder FVIII reduction (typically >25-30%) and X-linked inheritance cannot explain the pattern; Type 2A vWD would show decreased vWF activity; Acquired Hemophilia A would have a non-correcting mixing study; Factor XI deficiency would affect FXI, not FVIII. No logical flaws or medical inaccuracies. Minimal fix: None required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-004", "question": "A 19-year-old male presents with recurrent fevers, livedo reticularis, and two episodes of lacunar ischemic stroke. Laboratory evaluation reveals low serum IgM and IgG levels, mild neutropenia, and elevated inflammatory markers. A biopsy of a skin nodule shows necrotizing vasculitis. Genetic testing is most likely to reveal a loss-of-function mutation in which gene?", "options": ["MEFV", "ADA2", "NOD2", "TNFRSF1A", "STAT3"], "answer": "B", "answer_index": 1, "explanation": "This clinical presentation is classic for Deficiency of Adenosine Deaminase 2 (DADA2). It presents with a polyarteritis nodosa (PAN)-like vasculitis, early-onset strokes, and mild immunodeficiency (hypogammaglobulinemia/cytopenias). It is an autosomal recessive autoinflammatory disease. MEFV causes Familial Mediterranean Fever; STAT3 causes Hyper-IgE syndrome.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Immunology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The stem presents a classic triad for Deficiency of Adenosine Deaminase 2 (DADA2): early-onset lacunar strokes, PAN-like necrotizing vasculitis with livedo reticularis, and humoral immunodeficiency (hypogammaglobulinemia, neutropenia). These findings uniquely point to ADA2 loss-of-function. Key discriminating clues include: (1) lacunar strokes in a teenager, (2) necrotizing vasculitis on biopsy, (3) combined immunodeficiency pattern with low IgM/IgG. The keyed answer B (ADA2) aligns perfectly with current autoinflammatory disease classification and major guidelines. Alternative options are clearly inferior: MEFV (FMF) lacks vasculitic strokes and immunodeficiency; NOD2 causes granulomatous inflammation (Blau syndrome); TNFRSF1A (TRAPS) features different rash patterns and elevated IgA without hypogammaglobulinemia; STAT3 causes Hyper-IgE syndrome with elevated (not low) immunoglobulins. No logical flaws: the vignette is internally consistent, provides sufficient detail for a single best answer, and the key matches. Medical accuracy is excellent—DADA2 is an established autosomal recessive disease with this exact phenotype. No fixes required; item is board-ready as written.\",\"medical_accuracy_score\":   \t\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The stem presents a classic triad for Deficiency of Adenosine Deaminase 2 (DADA2): early-onset lacunar strokes, PAN-like necrotizing vasculitis with livedo reticularis, and humoral immunodeficiency (hypogammaglobulinemia, neutropenia). These findings uniquely point to ADA2 loss-of-function. Key discriminating clues include: (1) lacunar strokes in a teenager, (2) necrotizing vasculitis on biopsy, (3) combined immunodeficiency pattern with low IgM/IgG. The keyed answer B (ADA2) aligns perfectly with current autoinflammatory disease classification and major guidelines. Alternative options are clearly inferior: MEFV (FMF) lacks vasculitic strokes and immunodeficiency; NOD2 causes granulomatous inflammation (Blau syndrome); TNFRSF1A (TRAPS) features different rash patterns and elevated IgA without hypogammaglobulinemia; STAT3 causes Hyper-IgE syndrome with elevated (not low) immunoglobulins. No logical flaws: the vignette is internally consistent, provides sufficient detail for a single best answer, and the key matches. Medical accuracy is excellent—DADA2 is an established autosomal recessive disease with this exact phenotype. No fixes required; item is board-ready as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-005", "question": "A 65-year-old male with metastatic colorectal cancer is being evaluated for third-line therapy. Molecular profiling reveals the tumor is KRAS wild-type, NRAS wild-type, and BRAF V600E mutated. Microsatellite status is stable (MSS). Which of the following regimens is the most appropriate targeted therapy?", "options": ["Vemurafenib monotherapy", "Encorafenib plus Cetuximab", "Dabrafenib plus Trametinib", "Pembrolizumab monotherapy", "Regorafenib monotherapy"], "answer": "B", "answer_index": 1, "explanation": "In BRAF V600E-mutated colorectal cancer, BRAF inhibitor monotherapy (e.g., Vemurafenib) is ineffective due to a feedback loop that causes rapid upregulation of EGFR signaling. The standard of care, based on the BEACON trial, is the combination of a BRAF inhibitor (Encorafenib) and an EGFR inhibitor (Cetuximab) to block this feedback loop. Pembrolizumab is only for MSI-High tumors.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Medical Oncology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The stem identifies metastatic colorectal cancer with BRAF V600E mutation, MSS status, and wild-type KRAS/NRAS in a third-line setting. Key discriminating clues are the BRAF V600E mutation (present) and MSS status (excluding immunotherapy). The BEACON trial established encorafenib plus cetuximab as the standard targeted therapy for this molecular subtype, addressing EGFR feedback loop upregulation from BRAF inhibition. Option B directly matches this evidence-based regimen. Alternative analysis: A (vemurafenib monotherapy) is ineffective due to rapid resistance; C (dabrafenib/trametinib) is a melanoma regimen not validated in CRC; D (pembrolizumab) is contraindicated in MSS tumors; E (regorafenib) is a valid third-line option but lacks specific BRAF targeting, making B superior for this molecular profile. No internal contradictions exist. Medical accuracy is excellent: aligns with NCCN/ESMO guidelines and BEACON data. The question tests a high-yield molecular therapeutic principle. Minimal fix: None required; question is board-ready as written.\",\"medical_accuracy_score\":  \t\"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The stem identifies metastatic colorectal cancer with BRAF V600E mutation, MSS status, and wild-type KRAS/NRAS in a third-line setting. Key discriminating clues are the BRAF V600E mutation (present) and MSS status (excluding immunotherapy). The BEACON trial established encorafenib plus cetuximab as the standard targeted therapy for this molecular subtype, addressing EGFR feedback loop upregulation from BRAF inhibition. Option B directly matches this evidence-based regimen. Alternative analysis: A (vemurafenib monotherapy) is ineffective due to rapid resistance; C (dabrafenib/trametinib) is a melanoma regimen not validated in CRC; D (pembrolizumab) is contraindicated in MSS tumors; E (regorafenib) is a valid third-line option but lacks specific BRAF targeting, making B superior for this molecular profile. No internal contradictions exist. Medical accuracy is excellent: aligns with NCCN/ESMO guidelines and BEACON data. The question tests a high-yield molecular therapeutic principle. Minimal fix: None required; question is board-ready as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-006", "question": "A 45-year-old male presents with recurrent episodes of hypotension and syncope occurring 3 to 6 hours after eating dinner. He has no history of atopy. Skin prick tests to beef, pork, and lamb are negative, but intradermal testing is positive. Serum tryptase is normal. Specific IgE testing reveals elevated IgE to galactose-alpha-1,3-galactose. Which of the following is the most likely vector for sensitization in this patient?", "options": ["Ixodes scapularis (Black-legged tick)", "Amblyomma americanum (Lone Star tick)", "Dermacentor variabilis (American Dog tick)", "Aedes aegypti (Mosquito)", "Ctenocephalides felis (Cat flea)"], "answer": "B", "answer_index": 1, "explanation": "This is Alpha-gal syndrome, a delayed anaphylactic reaction to mammalian meat (red meat) mediated by IgE against the alpha-gal carbohydrate. Sensitization is caused by bites from the Lone Star tick (*Amblyomma americanum*) in the US. The reaction is characteristically delayed (3-6 hours) unlike typical protein-based food allergies.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Allergy/Immunology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The stem's constellation of delayed anaphylaxis (hypotension/syncope 3-6 hours after dinner), negative skin prick but positive intradermal testing to mammalian meats, normal serum tryptase, and elevated specific IgE to galactose-alpha-1,3-galactose definitively establishes alpha-gal syndrome. The Lone Star tick (Amblyomma americanum) is the well-documented primary sensitization vector in the United States, making option B uniquely defensible. Alternative options are unequivocally incorrect: Ixodes scapularis transmits Lyme disease; Dermacentor variabilis lacks alpha-gal association; Aedes aegypti (mosquito) and Ctenocephalides felis (flea) are insects without any established link. No internal contradictions exist, and options permit clear discrimination. Medical accuracy is gold-standard: the delayed presentation, diagnostic approach (specific IgE testing), and vector association align precisely with ACAAI/AAAAI consensus and current literature. The item is clinically realistic, board-relevant, and teaches a high-yield syndrome. No modifications needed.\",\"medical_accuracy_score\":  \"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The stem's constellation of delayed anaphylaxis (hypotension/syncope 3-6 hours after dinner), negative skin prick but positive intradermal testing to mammalian meats, normal serum tryptase, and elevated specific IgE to galactose-alpha-1,3-galactose definitively establishes alpha-gal syndrome. The Lone Star tick (Amblyomma americanum) is the well-documented primary sensitization vector in the United States, making option B uniquely defensible. Alternative options are unequivocally incorrect: Ixodes scapularis transmits Lyme disease; Dermacentor variabilis lacks alpha-gal association; Aedes aegypti (mosquito) and Ctenocephalides felis (flea) are insects without any established link. No internal contradictions exist, and options permit clear discrimination. Medical accuracy is gold-standard: the delayed presentation, diagnostic approach (specific IgE testing), and vector association align precisely with ACAAI/AAAAI consensus and current literature. The item is clinically realistic, board-relevant, and teaches a high-yield syndrome. No modifications needed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-007", "question": "A 78-year-old female is evaluated for progressive visual dysfunction. She reports difficulty reading and navigating her home, often bumping into doorframes. Her family notes she cannot reach for objects accurately (optic ataxia) and cannot describe the entire scene of a picture (simultanagnosia). Memory and language are relatively preserved. MRI shows predominant atrophy of the parietal and occipital lobes. What is the most likely underlying pathology?", "options": ["Lewy Body Disease", "Prion Disease (CJD)", "Alzheimer's Disease pathology (Amyloid plaques/Tau tangles)", "Frontotemporal Lobar Degeneration (TDP-43)", "Vascular Dementia"], "answer": "C", "answer_index": 2, "explanation": "This patient presents with Posterior Cortical Atrophy (PCA), also known as Benson's syndrome. The clinical hallmark is Balint's syndrome (simultanagnosia, optic ataxia, oculomotor apraxia) and Gerstmann's syndrome. Despite the atypical visual presentation, the underlying pathology in the vast majority (>80%) of PCA cases is Alzheimer's disease (amyloid plaques and neurofibrillary tangles).", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Geriatrics", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. This item tests recognition of Posterior Cortical Atrophy (PCA), an atypical Alzheimer disease variant. Key discriminating clues include progressive visual-spatial dysfunction with optic ataxia and simultanagnosia (Balint syndrome components), relatively preserved memory/language, and MRI showing parietal-occipital atrophy. These features point to PCA, which is pathologically Alzheimer disease (amyloid plaques/tau tangles) in >80% of cases. The keyed answer C is strongly supported by these findings and current neuropathological literature. Alternative options are appropriately less plausible: Lewy body disease (A) would feature hallucinations/fluctuations; CJD (B) is rapidly progressive; FTD-TDP (D) affects behavior/language with frontal/anterior atrophy; vascular dementia (E) shows stepwise decline and infarcts. No internal contradictions exist, and the stem provides sufficient detail for a single best answer. Medical accuracy is excellent: the association between PCA and AD pathology is well-established, and the clinical description is classic. The item is board-relevant and teaches an important atypical AD presentation. Minimal fix: None required; the item is sound as written.\",\"medical_accuracy_score\":  \"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. This item tests recognition of Posterior Cortical Atrophy (PCA), an atypical Alzheimer disease variant. Key discriminating clues include progressive visual-spatial dysfunction with optic ataxia and simultanagnosia (Balint syndrome components), relatively preserved memory/language, and MRI showing parietal-occipital atrophy. These features point to PCA, which is pathologically Alzheimer disease (amyloid plaques/tau tangles) in >80% of cases. The keyed answer C is strongly supported by these findings and current neuropathological literature. Alternative options are appropriately less plausible: Lewy body disease (A) would feature hallucinations/fluctuations; CJD (B) is rapidly progressive; FTD-TDP (D) affects behavior/language with frontal/anterior atrophy; vascular dementia (E) shows stepwise decline and infarcts. No internal contradictions exist, and the stem provides sufficient detail for a single best answer. Medical accuracy is excellent: the association between PCA and AD pathology is well-established, and the clinical description is classic. The item is board-relevant and teaches an important atypical AD presentation. Minimal fix: None required; the item is sound as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-008", "question": "A 28-year-old male with ulcerative colitis is admitted with jaundice and pruritus. MRCP shows multifocal strictures and dilations of the intrahepatic and extrahepatic bile ducts. IgG4 levels are 2x upper limit of normal. A liver biopsy shows periductal concentric fibrosis ('onion-skinning') without abundant plasma cells. A trial of high-dose corticosteroids results in no biochemical improvement. What is the diagnosis?", "options": ["IgG4-related Sclerosing Cholangitis", "Primary Sclerosing Cholangitis (PSC)", "Cholangiocarcinoma", "Secondary Sclerosing Cholangitis", "Autoimmune Hepatitis overlap syndrome"], "answer": "B", "answer_index": 1, "explanation": "This is classic Primary Sclerosing Cholangitis (PSC) associated with IBD. While IgG4 can be elevated in PSC (up to 15% of cases), the lack of response to steroids and the classic 'onion-skin' fibrosis distinguish it from IgG4-related Sclerosing Cholangitis (IgG4-SC). IgG4-SC typically responds dramatically to steroids and shows abundant IgG4+ plasma cells on biopsy.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V (Valid). Verdict: Correct best answer. Key stem clues driving diagnosis: (1) Ulcerative colitis association strongly points to PSC; (2) MRCP with multifocal intra- and extrahepatic strictures/dilations is classic PSC cholangiography; (3) Liver biopsy showing periductal concentric 'onion-skin' fibrosis without abundant plasma cells is pathognomonic for PSC and excludes IgG4-related disease; (4) Steroid non-response distinguishes from IgG4-related sclerosing cholangitis, which shows dramatic biochemical improvement; (5) IgG4 elevation (2× ULN) can occur in PSC but lacks diagnostic histologic features of IgG4-SC. Alternative choices are clearly inferior: IgG4-SC (A) would have IgG4-rich plasma cell infiltrate and steroid responsiveness; cholangiocarcinoma (C) would show a mass, not diffuse beading; secondary sclerosing cholangitis (D) is less specific and typically lacks IBD association; autoimmune hepatitis overlap (E) would have interface hepatitis and steroid responsiveness. No logical flaws or medical inaccuracies. Item is board-style perfect and requires no revision.\",\"medical_accuracy_score\":   \"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict: Correct best answer. Key stem clues driving diagnosis: (1) Ulcerative colitis association strongly points to PSC; (2) MRCP with multifocal intra- and extrahepatic strictures/dilations is classic PSC cholangiography; (3) Liver biopsy showing periductal concentric 'onion-skin' fibrosis without abundant plasma cells is pathognomonic for PSC and excludes IgG4-related disease; (4) Steroid non-response distinguishes from IgG4-related sclerosing cholangitis, which shows dramatic biochemical improvement; (5) IgG4 elevation (2× ULN) can occur in PSC but lacks diagnostic histologic features of IgG4-SC. Alternative choices are clearly inferior: IgG4-SC (A) would have IgG4-rich plasma cell infiltrate and steroid responsiveness; cholangiocarcinoma (C) would show a mass, not diffuse beading; secondary sclerosing cholangitis (D) is less specific and typically lacks IBD association; autoimmune hepatitis overlap (E) would have interface hepatitis and steroid responsiveness. No logical flaws or medical inaccuracies. Item is board-style perfect and requires no revision.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-009", "question": "A 60-year-old female undergoes surveillance colonoscopy. A 15mm flat lesion is removed from the ascending colon. Pathology reveals a Sessile Serrated Lesion (SSL) with dysplasia. According to the 2020 US Multi-Society Task Force guidelines, when should her next surveillance colonoscopy be performed?", "options": ["1 year", "3 years", "5 years", "7 years", "10 years"], "answer": "B", "answer_index": 1, "explanation": "Sessile Serrated Lesions (SSLs) with dysplasia are considered high-risk precancerous lesions, equivalent in risk to high-risk adenomas (e.g., villous histology, high-grade dysplasia, or size >10mm). The recommended surveillance interval for an SSL with dysplasia (regardless of size) is 3 years. An SSL <10mm without dysplasia would be 5-10 years.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The stem provides adequate detail: 15mm sessile serrated lesion (SSL) with dysplasia in the ascending colon. According to 2020 US Multi-Society Task Force guidelines, SSL with dysplasia is a high-risk lesion meriting 3-year surveillance regardless of size; the 15mm dimension independently qualifies. Key discriminating findings are the dysplasia designation and lesion size. Option B (3 years) aligns directly with guideline recommendations for high-risk serrated lesions. Alternative options are appropriately excluded: 1 year (A) is reserved for piecemeal resection or serrated polyposis syndrome; 5 years (C) applies to low-risk adenomas or small SSLs without dysplasia; 7 and 10 years (D, E) are not standard surveillance intervals for high-risk pathology. No internal contradictions exist, and the options permit clear discrimination. Medical accuracy is excellent: the rationale correctly equates SSL with dysplasia to other high-risk adenomas and properly distinguishes from surveillance intervals for non-dysplastic SSLs. No factual errors or outdated guidance present. Minimal fix: none required; item is board-ready as written.\",\"medical_accuracy_score\":   \"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The stem provides adequate detail: 15mm sessile serrated lesion (SSL) with dysplasia in the ascending colon. According to 2020 US Multi-Society Task Force guidelines, SSL with dysplasia is a high-risk lesion meriting 3-year surveillance regardless of size; the 15mm dimension independently qualifies. Key discriminating findings are the dysplasia designation and lesion size. Option B (3 years) aligns directly with guideline recommendations for high-risk serrated lesions. Alternative options are appropriately excluded: 1 year (A) is reserved for piecemeal resection or serrated polyposis syndrome; 5 years (C) applies to low-risk adenomas or small SSLs without dysplasia; 7 and 10 years (D, E) are not standard surveillance intervals for high-risk pathology. No internal contradictions exist, and the options permit clear discrimination. Medical accuracy is excellent: the rationale correctly equates SSL with dysplasia to other high-risk adenomas and properly distinguishes from surveillance intervals for non-dysplastic SSLs. No factual errors or outdated guidance present. Minimal fix: none required; item is board-ready as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-010", "question": "A 55-year-old male with AL amyloidosis presents with extensive ecchymoses and a large hematoma after a minor venipuncture. Coagulation studies reveal a PT of 18s (Normal 11-13.5) and a PTT of 45s (Normal 25-35). Thrombin time is normal. Mixing studies correct both PT and PTT. Factor assays reveal Factor X activity of 8%. What is the mechanism of this deficiency?", "options": ["Autoantibody inhibition of Factor X", "Adsorption of Factor X onto amyloid fibrils", "Decreased hepatic synthesis of Factor X", "Urinary loss of Factor X due to nephrotic syndrome", "Consumption due to low-grade DIC"], "answer": "B", "answer_index": 1, "explanation": "Acquired Factor X deficiency is a rare but classic complication of AL amyloidosis (occurring in ~8-10% of patients). The mechanism is the adsorption (binding) of Factor X to the amyloid fibrils in the spleen and liver, removing it from circulation. It is not an inhibitor (antibody) or synthesis issue. Treatment often requires splenectomy or high-dose factor replacement to overwhelm the binding sites.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Hematology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V (logically sound). Verdict: The keyed answer B is the correct best answer. Key discriminating clues: (1) AL amyloidosis, a known cause of acquired factor X deficiency; (2) prolonged PT and PTT that correct on mixing, indicating a factor deficiency rather than an inhibitor; (3) isolated severe reduction of factor X activity (8 %) with normal thrombin time, consistent with factor X loss; (4) clinical bleeding after minor trauma. These features uniquely point to adsorption of factor X onto amyloid fibrils. Alternative options are implausible: autoantibody would not correct on mixing; hepatic synthesis defect is unlikely without liver disease; urinary loss is not supported by the vignette; DIC would show consumption of multiple factors and elevated D‑dimer. No internal contradictions exist. Medical accuracy: The mechanism of adsorption onto amyloid fibrils is well‑established in AL amyloidosis and aligns with current hematology literature; the laboratory pattern is correctly described. No safety concerns. Minimal fix: Add a brief statement such as \\\"Liver function tests are normal and urine protein is negative\\\" to explicitly exclude hepatic or renal loss mechanisms, further sharpening discrimination.\",\n\"medical_accuracy_score\":  \t \t \t \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (logically sound). Verdict: The keyed answer B is the correct best answer. Key discriminating clues: (1) AL amyloidosis, a known cause of acquired factor X deficiency; (2) prolonged PT and PTT that correct on mixing, indicating a factor deficiency rather than an inhibitor; (3) isolated severe reduction of factor X activity (8 %) with normal thrombin time, consistent with factor X loss; (4) clinical bleeding after minor trauma. These features uniquely point to adsorption of factor X onto amyloid fibrils. Alternative options are implausible: autoantibody would not correct on mixing; hepatic synthesis defect is unlikely without liver disease; urinary loss is not supported by the vignette; DIC would show consumption of multiple factors and elevated D‑dimer. No internal contradictions exist. Medical accuracy: The mechanism of adsorption onto amyloid fibrils is well‑established in AL amyloidosis and aligns with current hematology literature; the laboratory pattern is correctly described. No safety concerns. Minimal fix: Add a brief statement such as \"Liver function tests are normal and urine protein is negative\" to explicitly exclude hepatic or renal loss mechanisms, further sharpening discrimination.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-011", "question": "A 30-year-old female presents with recurrent sinopulmonary infections and splenomegaly. Labs show low IgG, low IgA, and variable IgM. She is diagnosed with Common Variable Immunodeficiency (CVID). Five years later, she develops progressive dyspnea. CT chest shows diffuse pulmonary nodules and mediastinal lymphadenopathy. Biopsy reveals non-necrotizing granulomas. Stains for fungi and mycobacteria are negative. What is the preferred initial treatment for this complication?", "options": ["Infliximab", "Rituximab and Azathioprine/Mycophenolate", "High-dose Intravenous Immunoglobulin (IVIG) alone", "Lung Transplantation", "Antituberculous therapy"], "answer": "B", "answer_index": 1, "explanation": "The patient has Granulomatous-Lymphocytic Interstitial Lung Disease (GLILD), a distinct and serious complication of CVID. Unlike sarcoidosis, GLILD in CVID is driven by B-cell hyperplasia and T-cell dysregulation. The consensus treatment for progressive GLILD is combination immunosuppression, typically Rituximab (to deplete B cells) combined with an antimetabolite like Azathioprine or Mycophenolate. IVIG alone is insufficient for GLILD.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Immunology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. Key stem clues establishing GLILD in CVID include: prior CVID diagnosis (low IgG/IgA), new progressive dyspnea, CT showing diffuse nodules/lymphadenopathy, and biopsy with non-necrotizing granulomas negative for infection. These findings specifically point to Granulomatous-Lymphocytic Interstitial Lung Disease (GLILD), a serious and distinct CVID complication. The question asks for preferred initial treatment. Option B (Rituximab + Azathioprine/Mycophenolate) is the consensus first-line immunosuppressive regimen for progressive GLILD, targeting B-cell hyperplasia and T-cell dysregulation. Alternative analysis: Infliximab (A) is inappropriate as anti-TNF therapy is not first-line for GLILD; IVIG alone (C) treats CVID but is insufficient for GLILD; Lung transplant (D) is reserved for end-stage refractory disease; Antituberculous therapy (E) is contraindicated by negative stains. No logical flaws: stem provides adequate discrimination, options are mutually exclusive, and the key matches the single best answer. Medical accuracy is gold-standard: aligns with current ESID/AAAAI consensus and recent literature describing GLILD pathophysiology and management. No fixes required.\",\"medical_accuracy_score\":   \t\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. Key stem clues establishing GLILD in CVID include: prior CVID diagnosis (low IgG/IgA), new progressive dyspnea, CT showing diffuse nodules/lymphadenopathy, and biopsy with non-necrotizing granulomas negative for infection. These findings specifically point to Granulomatous-Lymphocytic Interstitial Lung Disease (GLILD), a serious and distinct CVID complication. The question asks for preferred initial treatment. Option B (Rituximab + Azathioprine/Mycophenolate) is the consensus first-line immunosuppressive regimen for progressive GLILD, targeting B-cell hyperplasia and T-cell dysregulation. Alternative analysis: Infliximab (A) is inappropriate as anti-TNF therapy is not first-line for GLILD; IVIG alone (C) treats CVID but is insufficient for GLILD; Lung transplant (D) is reserved for end-stage refractory disease; Antituberculous therapy (E) is contraindicated by negative stains. No logical flaws: stem provides adequate discrimination, options are mutually exclusive, and the key matches the single best answer. Medical accuracy is gold-standard: aligns with current ESID/AAAAI consensus and recent literature describing GLILD pathophysiology and management. No fixes required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-012", "question": "A 62-year-old male with metastatic melanoma is treated with Ipilimumab and Nivolumab. Four weeks after the second cycle, he presents with fatigue, nausea, and hypotension. Labs show Sodium 130 mEq/L, Potassium 5.2 mEq/L, Glucose 65 mg/dL. TSH is 0.05 mIU/L (Low), Free T4 is 0.6 ng/dL (Low). ACTH is <5 pg/mL. MRI brain shows enlargement of the pituitary gland. What is the diagnosis?", "options": ["Primary Adrenal Insufficiency (Addison's)", "Immune Checkpoint Inhibitor-induced Hypophysitis", "Thyroid Storm", "Pituitary Metastasis", "Syndrome of Inappropriate ADH (SIADH)"], "answer": "B", "answer_index": 1, "explanation": "This is a classic presentation of hypophysitis (inflammation of the pituitary), a specific immune-related adverse event (irAE) strongly associated with CTLA-4 inhibitors (Ipilimumab). The key biochemical pattern is central hypothyroidism (Low TSH, Low T4) and central adrenal insufficiency (Low ACTH, Low Cortisol, hyponatremia/hyperkalemia). Primary adrenal insufficiency would have high ACTH. The MRI finding confirms pituitary inflammation.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Medical Oncology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V (valid). The vignette provides a classic presentation of immune checkpoint inhibitor–induced hypophysitis. Key clues: metastatic melanoma on ipilimumab (CTLA‑4 inhibitor), onset 4 weeks after cycle, fatigue/nausea/hypotension, hyponatremia, hyperkalemia, hypoglycemia, low TSH with low free T4 (central hypothyroidism), low ACTH (central adrenal insufficiency), and MRI pituitary enlargement. These findings together point to hypophysitis rather than primary adrenal failure (which would have high ACTH), thyroid storm (would have high TSH and high T4), SIADH (no hyperkalemia/hypoglycemia), or pituitary metastasis (less likely given timing and irAE context). The keyed answer B is therefore the single best choice. Logical validity is intact: only one option fits all data, no internal contradictions, and the key matches it. Medical accuracy is high; the pattern of central hypothyroidism plus secondary adrenal insufficiency after CTLA‑4 blockade is well‑established. A minor nuance: hyperkalemia is more typical of primary adrenal insufficiency; in central disease aldosterone is usually preserved, so hyperkalemia is less expected. This does not invalidate the item but could be clarified. Minimal fix: add a brief note that hyperkalemia can be seen in severe cortisol deficiency or omit it to avoid confusion.\",\n\"medical_accuracy_score\":  \t \t \t \t\"4\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (valid). The vignette provides a classic presentation of immune checkpoint inhibitor–induced hypophysitis. Key clues: metastatic melanoma on ipilimumab (CTLA‑4 inhibitor), onset 4 weeks after cycle, fatigue/nausea/hypotension, hyponatremia, hyperkalemia, hypoglycemia, low TSH with low free T4 (central hypothyroidism), low ACTH (central adrenal insufficiency), and MRI pituitary enlargement. These findings together point to hypophysitis rather than primary adrenal failure (which would have high ACTH), thyroid storm (would have high TSH and high T4), SIADH (no hyperkalemia/hypoglycemia), or pituitary metastasis (less likely given timing and irAE context). The keyed answer B is therefore the single best choice. Logical validity is intact: only one option fits all data, no internal contradictions, and the key matches it. Medical accuracy is high; the pattern of central hypothyroidism plus secondary adrenal insufficiency after CTLA‑4 blockade is well‑established. A minor nuance: hyperkalemia is more typical of primary adrenal insufficiency; in central disease aldosterone is usually preserved, so hyperkalemia is less expected. This does not invalidate the item but could be clarified. Minimal fix: add a brief note that hyperkalemia can be seen in severe cortisol deficiency or omit it to avoid confusion.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-013", "question": "A 22-year-old female presents with recurrent episodes of abdominal pain and extremity swelling lasting 2-3 days. She has no urticaria during these episodes. Her C4 level is consistently low. C1-Inhibitor (C1-INH) quantitative level is 8 mg/dL (Normal 19-37) and C1-INH functional activity is 15% (Normal >68%). Which of the following is the most appropriate long-term prophylactic therapy?", "options": ["Antihistamines (Cetirizine)", "Omalizumab", "Danazol or Lanadelumab", "Systemic Corticosteroids", "Epinephrine auto-injector"], "answer": "C", "answer_index": 2, "explanation": "The patient has Hereditary Angioedema (HAE) Type 1 (low C1-INH level and function). HAE is bradykinin-mediated, not histamine-mediated; therefore, antihistamines, corticosteroids, and epinephrine are ineffective. Long-term prophylaxis is indicated for frequent attacks. Options include attenuated androgens (Danazol) or modern agents like Lanadelumab (kallikrein inhibitor) or Berotralstat. C1-INH replacement is also used.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Allergy/Immunology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. Stem establishes Hereditary Angioedema (HAE) Type 1: recurrent angioedema without urticaria, low C4, and markedly reduced C1-INH quantity (8 mg/dL) and function (15%). This bradykinin-mediated disease renders antihistamines, corticosteroids, and epinephrine ineffective, correctly eliminating A, D, and E. Omalizumab (B) targets IgE and is irrelevant. Answer C appropriately lists two guideline-endorsed long-term prophylaxis options: danazol (attenuated androgen) and lanadelumab (kallikrein inhibitor). While modern practice favors lanadelumab for its superior safety profile, danazol remains acceptable, and the combined format is defensible given clear superiority over alternatives. No contradictions or critical missing details prevent a unique best answer. Medical accuracy aligns with current HAE management standards and FDA-approved therapies. Minor format issue: single-best-answer items typically separate distinct therapies for precision. Minimal fix: Split C into distinct choices or add stem context (e.g., pregnancy planning, hepatic concerns) to preferentially select lanadelumab.\",\"medical_accuracy_score\":   \"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. Stem establishes Hereditary Angioedema (HAE) Type 1: recurrent angioedema without urticaria, low C4, and markedly reduced C1-INH quantity (8 mg/dL) and function (15%). This bradykinin-mediated disease renders antihistamines, corticosteroids, and epinephrine ineffective, correctly eliminating A, D, and E. Omalizumab (B) targets IgE and is irrelevant. Answer C appropriately lists two guideline-endorsed long-term prophylaxis options: danazol (attenuated androgen) and lanadelumab (kallikrein inhibitor). While modern practice favors lanadelumab for its superior safety profile, danazol remains acceptable, and the combined format is defensible given clear superiority over alternatives. No contradictions or critical missing details prevent a unique best answer. Medical accuracy aligns with current HAE management standards and FDA-approved therapies. Minor format issue: single-best-answer items typically separate distinct therapies for precision. Minimal fix: Split C into distinct choices or add stem context (e.g., pregnancy planning, hepatic concerns) to preferentially select lanadelumab.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-014", "question": "A 72-year-old male is evaluated for frequent falls. He reports that his legs feel 'heavy' and 'stuck to the floor' when he tries to start walking, but once moving, he can walk relatively well. He has urinary urgency and mild cognitive impairment. Physical exam reveals a broad-based, shuffling gait with difficulty lifting feet (magnetic gait). What is the most likely diagnosis?", "options": ["Parkinson's Disease", "Normal Pressure Hydrocephalus (NPH)", "Lumbar Spinal Stenosis", "Vascular Dementia", "Cerebellar Ataxia"], "answer": "B", "answer_index": 1, "explanation": "The clinical triad of gait disturbance, urinary incontinence (urgency), and dementia ('wobbly, wet, and wacky') suggests Normal Pressure Hydrocephalus (NPH). The specific description of a 'magnetic gait' (gait apraxia where feet appear stuck to the floor) is the hallmark and usually the earliest sign. It is distinguished from Parkinson's by the lack of resting tremor and the specific nature of the gait initiation failure.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Geriatrics", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V (Valid). Verdict: Correct best answer. Key stem clues: 72-year-old male with the classic NPH triad—magnetic gait (feet 'stuck to floor' with initiation failure but relatively preserved ambulation once started), urinary urgency, and mild cognitive impairment. The broad-based, shuffling, apraxic gait pattern is the critical discriminator. Main logical issue: None. The vignette supplies sufficient positive and negative findings: absence of resting tremor, rigidity, or bradykinesia effectively excludes Parkinson's disease; lack of neurogenic claudication, back pain, or leg weakness makes lumbar spinal stenosis unlikely; no stepwise cognitive decline, focal neuro deficits, or history of strokes argues against vascular dementia; and absence of dysmetria, nystagmus, or true cerebellar signs rules out cerebellar ataxia. Main medical accuracy issue: None. The item accurately captures the 'wobbly, wet, wacky' triad and correctly identifies magnetic gait apraxia as NPH's hallmark manifestation. Minimal fix: None required; the item is board-exam caliber with precise language enabling unambiguous discrimination.\",\"medical_accuracy_score\":  \"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict: Correct best answer. Key stem clues: 72-year-old male with the classic NPH triad—magnetic gait (feet 'stuck to floor' with initiation failure but relatively preserved ambulation once started), urinary urgency, and mild cognitive impairment. The broad-based, shuffling, apraxic gait pattern is the critical discriminator. Main logical issue: None. The vignette supplies sufficient positive and negative findings: absence of resting tremor, rigidity, or bradykinesia effectively excludes Parkinson's disease; lack of neurogenic claudication, back pain, or leg weakness makes lumbar spinal stenosis unlikely; no stepwise cognitive decline, focal neuro deficits, or history of strokes argues against vascular dementia; and absence of dysmetria, nystagmus, or true cerebellar signs rules out cerebellar ataxia. Main medical accuracy issue: None. The item accurately captures the 'wobbly, wet, wacky' triad and correctly identifies magnetic gait apraxia as NPH's hallmark manifestation. Minimal fix: None required; the item is board-exam caliber with precise language enabling unambiguous discrimination.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]